DFX Intelligence

Data Factory

Paragon Bioservices, Inc.

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:7d6f3cba-d336-44b2-9ed9-68fb707402f0

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 11:37 AM UTC and rebuilt at most every 15 minutes.

Relationships: 5
Dated events: 2
On other graphs: 1
Observed: Sep 13, 2026 to Sep 17, 2026
1 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Paragon Bioservices, Inc.

Venture-backed company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Owners: Leonard Green & Partners, L.P., Camden Private Capital, Camden Partners Holdings, LLC
Owned since: May 20, 2019
Add-ons on file: 0add-on transactions linked to this company on the graph
Transactions: 2
Investors: 3

Transactions

Announced	Type	Headline	EV	Basis
May 20, 2019	Add on acquisition	Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion	n/a	n/a

Investors

Investor	Class	Role	Control	Invested	Status
Leonard Green & Partners, L.P.	Buyout	Add on	control	May 20, 2019	active
Camden Private Capital	Buyout	unknown	unknown	n/a	active
Camden Partners Holdings, LLC	Buyout	unknown	unknown	n/a	active

Relationships

Invested in (3)

← Camden Private CapitalFirmunknown
factDFX's own graph
← Camden Partners Holdings, LLCFirmunknown
factDFX's own graph, The subject's own site
← Leonard Green & Partners, L.P.FirmAdd on
May 20, 2019 to presentfactNews and newswire

Add on of (1)

→ CatalentCompany
May 20, 2019 to presentfactNews and newswire

Dated events

Occurred
May 20, 2019
Transaction announced
Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
Leonard Green & Partners, L.P.News and newswireobserved 5 days ago
Occurred
May 20, 2019
Add-on acquired
Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
News and newswireobserved 5 days ago

Provenance

Graph: Private Equity
Canonical id: dfx:pe:7d6f3cba-d336-44b2-9ed9-68fb707402f0
First observed: Sep 13, 2026
Last observed: Sep 17, 2026 2 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Paragon Bioservices, Inc.

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:7d6f3cba-d336-44b2-9ed9-68fb707402f0

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 19, 2026, 11:37 AM UTC and rebuilt at most every 15 minutes.

Announced

Type

Headline

Basis

May 20, 2019

Add on acquisition

Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion

n/a

Investor

Class

Role

Control

Invested

Status

Leonard Green & Partners, L.P.

Buyout

Add on

control

May 20, 2019

active

Camden Private Capital

Buyout

unknown

n/a

active

Camden Partners Holdings, LLC

Buyout

unknown

n/a

active